Concepedia

Robert N. Schuck

RN

Statistics

Publications

20

Citations

1.1K

H-Index

18

Active since

2008

Affiliations

University of North Carolina at Chapel Hill(Current)

Center for Drug Evaluation and Research

National Institute of Environmental Health Sciences

National Institutes of Health

United States Food and Drug Administration

Robert N. Schuck is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and atherosclerosis.

Top concepts

MedicinePharmacologyAtherosclerosisPhysiologyVascular BiologyCardiovascular DiseaseInflammationPharmacotherapyOxidative StressHealth

Publications per year

2008–2024

20

Publications

20

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 158 citations

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

Yangmei Deng, Matthew L. Edin, Katherine N. Theken et al. · The FASEB Journal · 2010 · 132 citations

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +23

Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease

Katherine N. Theken, Robert N. Schuck, Matthew L. Edin et al. · Atherosclerosis · 2012 · 107 citations · Full text

Metabolic Syndrome, Oxysterol, Cardiovascular Disease +10

The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease

Robert N. Schuck, Weibin Zha, Matthew L. Edin et al. · PLoS ONE · 2014 · 94 citations · Full text

Pathology, Fatty Liver Disease, Oxidative Stress +18

Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity

Weibin Zha, Matthew L. Edin, Kimberly C. Vendrov et al. · Journal of Lipid Research · 2014 · 86 citations · Full text

1–5 of 20